Decreasing Antibiotic Prescribing in Acute Respiratory Infections Through Nurse Driven Clinical Decision Support
NCT04255303
Acute Respiratory Infection
New York, United States
View Trial DetailsNCT Number: NCT05322694
Acute respiratory infections (such as influenza-like illness and upper respiratory tract infection) and acute infectious diarrhea are, for the most part, conditions that do not require medical management or specific treatment. Depending on the level of their transmission in the community, however, these diseases place significant clinical and financial burden on the healthcare system, particularly on emergency departments (ED). The investigators propose a prospective multicenter cohort study with which they aim to validate clinical decision rules combining 1) rapid molecular tests and 2) risk stratification tools to identify patients at low risk for complications related to acute respiratory infection and acute infectious diarrhea. The use of these clinical decision rules by nurses in ED triage could allow low-risk patients to be sent directly home for self-treatment without having to see the emergency physician. By eliminating the need for physician assessment, paraclinical testing and prolonged waiting in the ED, these triage-based clinical decision rules could provide a new, safe care pathway for acute respiratory infections and acute infectious diarrhea, reducing the burden on the patient, the healthcare system, and society.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Centre hospitalier universitaire de Montréal, Montreal, Quebec, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Acute Respiratory Infections :
Inclusion criteria
Exclusion criteria
Acute infectious diarrhea :
Inclusion criteria
Exclusion criteria
Time frame: 30 days
Combined proportion incidence at 7 and 30 days after the initial visit of ED returns, hospitalizations and deaths related to acute respiratory infection or acute infectious diarrhea (obtained from provincial administrative databases).
Time frame: 30 days
Incidence proportion of ED returns at 7 and 30 days after the initial visit.
Time frame: 7 days
Incidence of prescribing antiviral medication (e.g., oseltamivir) at the initial ED visit and at 7 days (telephone follow-up).
Time frame: 7 days
Incidence of antibiotic prescribing at initial visit and at 7 days (telephone follow-up).
Time frame: 30 days
Incidence of intensive care unit admission at 30 days (obtained from provincial administrative database on hospital admissions).
Time frame: 30 days
Mean costs of the initial ED visit from a health system perspective estimated using time-driven activity-based costing (data obtained from initial visit data collection, electronic medical records and provincial physician billing database).
Time frame: 7 days
Mean 7-day costs from the patient perspective (obtained from the Cost for Patient Questionnaire - the CoPaQ- administered at telephone follow-up).
Time frame: Measured from ED arrival to ED discharge on the initial visit (maximum 120 hours)
Length of stay in the ED on the initial visit (electronic medical records).
Time frame: 30 days
Incidence proportion of hospitalizations at 7 and 30 days after the initial visit.
Time frame: 30 days
Incidence proportion of deaths at 7 and 30 days after the initial visit.
Simon Berthelot
Other
Multicenter Prospective Cohort Study to Derive and Validate Clinical Decision Rules in Emergency Department Triage to Improve the Care Pathway for Patients With Acute Respiratory Infection or Acute Infectious Diarrhea.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04255303
Acute Respiratory Infection
New York, United States
View Trial DetailsNCT06981130
Acute Respiratory Infection
Merthyr Tydfil, Rhondda Cynon Taff, United Kingdom
View Trial DetailsNCT06183229
Acute Respiratory Infection, Infections
Saint Petersburg, Russia
View Trial DetailsNCT04844541
Acute Respiratory Infection, COVID-19
Baltimore, Maryland, United States
View Trial Details